Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:activeIngredient |
recombinant RBD protein of SARS-CoV-2
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:approvedBy |
July 2021
|
| gptkbp:associatedWith |
gptkb:Soberana_02
|
| gptkbp:category |
COVID-19 vaccines developed in Cuba
|
| gptkbp:clinicalTrialPhase3Location |
gptkb:Cuba
|
| gptkbp:countryOfOrigin |
gptkb:Cuba
|
| gptkbp:developedBy |
gptkb:Center_for_Genetic_Engineering_and_Biotechnology
|
| gptkbp:dosesRequired |
3
|
| gptkbp:efficacyAgainstSymptomaticCOVID19 |
92.28%
|
| gptkbp:emergencyServices |
gptkb:Cuba
gptkb:Venezuela gptkb:Vietnam |
| https://www.w3.org/2000/01/rdf-schema#label |
Abdala vaccine
|
| gptkbp:intervalBetweenDoses |
14 days
|
| gptkbp:namedAfter |
Abdala (poem by José Martí)
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
protein subunit vaccine
|
| gptkbp:WHOStatus |
not yet approved by WHO
|
| gptkbp:bfsParent |
gptkb:BioCubaFarma
gptkb:Center_for_Genetic_Engineering_and_Biotechnology |
| gptkbp:bfsLayer |
7
|